Related Experiment Video
Updated: Jul 30, 2025
05:40
Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs
Published on: December 22, 2023
340
Hypertonic glucose pleurodesis for preterm neonates with chylothorax
Kam Lun Ellis Hon1,2, Chuk Man Peter Hui2, Genevieve P G Fung3
1Department of Paediatrics, CUHKMC, The Chinese University of Hong Kong, Hong Kong SAR, China.
Pediatric Pulmonology
|May 12, 2023
Summary
Chylothorax in neonates can be challenging. This study shows 50% Dextrose (D50) effectively treated resistant chylothorax in premature infants, offering a new therapeutic option.
Area of Science:
- Neonatal Medicine
- Thoracic Surgery
- Pediatric Critical Care
Background:
- Chylothorax is a frequent complication post-cardiac surgery and a primary cause of pleural effusion in neonates.
- Standard treatments include conservative measures like Nil-per-Oral (NPO) and octreotide, with chemical pleurodesis for refractory cases.
- Established pleurodesis agents like talc and bleomycin have limitations.
Discussion:
- This study reports successful management of two premature infants with resistant chylothorax using 50% Dextrose (D50) for chemical pleurodesis.
- D50, previously shown effective in adults, was utilized as an alternative sclerosant.
- The cases highlight D50's potential in pediatric refractory chylothorax.
Key Insights:
- 50% Dextrose (D50) demonstrates efficacy as a chemical sclerosant for treating resistant neonatal chylothorax.
- Successful application in premature infants suggests a viable alternative to traditional pleurodesis agents.
- This approach offers a potential solution for challenging cases unresponsive to standard therapies.
Outlook:
- Further research is warranted to establish optimal D50 protocols for neonatal chylothorax.
- Investigating long-term outcomes and safety profiles of D50 pleurodesis in neonates is crucial.
- D50 may become a valuable tool in the management of pediatric pleural effusions.
More Related Videos
Related Concept Videos
01:26Endoscopic Studies II: Thoracocentesis
371
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
371
01:27Pneumothorax-II
225
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
225
01:25Pleural Effusion I: Introduction
1.3K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.3K
01:28Pleural Effusion II: Symptoms and Management
225
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
225